Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to David L. Wyles

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Wyles, David

One or more keywords matched the following items that are connected to Wyles, David

Item Type	Name
Concept	Hepatitis C, Chronic
Concept	Hepatitis B, Chronic
Academic Article	Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Academic Article	Hepatitis C virus drug resistance: implications for clinical management.
Academic Article	High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen.
Academic Article	Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.
Academic Article	Interferon ?-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
Academic Article	Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV).
Academic Article	Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection.
Academic Article	CROI 2016: Viral Hepatitis and Liver Fibrosis.
Academic Article	News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference.
Academic Article	Resistance to DAAs: When to Look and When It Matters.
Academic Article	Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection.
Academic Article	Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.
Academic Article	Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.
Academic Article	Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way more.
Academic Article	Early identification and linkage to care of persons with chronic hepatitis B virus infection--three U.S. sites, 2012-2014.
Academic Article	Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.
Academic Article	Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Academic Article	Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir.
Academic Article	Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.
Academic Article	Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir.
Academic Article	Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Academic Article	Sofosbuvir for previously untreated chronic hepatitis C infection.
Academic Article	Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
Academic Article	All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-na?ve patients with genotype 1 HCV infection.
Academic Article	CROI 2019: highlights of viral hepatitis.
Academic Article	Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease.
Academic Article	Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
Academic Article	Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
Academic Article	Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Academic Article	Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
Academic Article	Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
Academic Article	Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.
Academic Article	Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Academic Article	D?j? vu All Over Again: Retreatment of HCV Direct Acting Antivirals Failures-Same Satisfactory Results, Same Unanswered Questions.
Academic Article	A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.

Search Criteria

Hepatitis C Chronic